Literature DB >> 1394048

Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy.

J Jansma1, A Vissink, F K Spijkervet, J L Roodenburg, A K Panders, A Vermey, B G Szabó, E J Gravenmade.   

Abstract

In addition to the desired antitumor effects, head and neck radiation therapy induces damage in normal tissues that may result in oral sequelae such as mucositis, hyposalivation, radiation caries, taste loss, trismus, soft-tissue necrosis, and osteoradionecrosis. These sequelae may be dose-limiting and have a tremendous effect on the patient's quality of life. Current policies to prevent these sequelae primarily are based on clinical experience and show great diversity. A protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy, based on fundamental research and data derived from the literature, is presented. The protocol is particularly applicable in centers with a dental team. This team should be involved at the time of initial diagnosis so that a successful preventive regimen is an integral part of the overall cancer treatment regimen.

Entities:  

Mesh:

Year:  1992        PMID: 1394048     DOI: 10.1002/1097-0142(19921015)70:8<2171::aid-cncr2820700827>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

Review 1.  Barriers and strategies in implementation of oral care standards for cancer patients.

Authors:  Deborah B McGuire
Journal:  Support Care Cancer       Date:  2003-04-12       Impact factor: 3.603

Review 2.  Osteoradionecrosis of the jaws--a current overview--part 1: Physiopathology and risk and predisposing factors.

Authors:  Bruno Ramos Chrcanovic; Peter Reher; Alexandre Andrade Sousa; Malcolm Harris
Journal:  Oral Maxillofac Surg       Date:  2010-03

3.  [The impact of radiotherapy on quality of life -- a survey of 1411 patients with oral cancer].

Authors:  T R Hahn; G Krüskemper
Journal:  Mund Kiefer Gesichtschir       Date:  2007-04

Review 4.  [The use of sucralfate in radiation oncology].

Authors:  C Belka; W Hoffmann; F Paulsen; M Barnberg
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

5.  Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?

Authors:  Daan Nevens; Sandra Nuyts
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 6.  [Radiation-related caries: etiology and possible preventive strategies. What should the radiotherapist know?].

Authors:  R Schweyen; J Hey; W Fränzel; D Vordermark; G Hildebrandt; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

7.  Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjögren's syndrome.

Authors:  Tamara Peric; Dejan Markovic; Bojan Petrovic; Vesna Radojevic; Tatjana Todorovic; Biljana Andjelski Radicevic; Radmila Jancic Heinemann; Gordana Susic; Aleksandra Peric Popadic; Vesna Tomic Spiric
Journal:  Clin Oral Investig       Date:  2015-03-13       Impact factor: 3.573

8.  Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy.

Authors:  M Bansal; B K Mohanti; N Shah; R Chaudhry; S Bahadur; N K Shukla
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

9.  Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.

Authors:  I H Liem; R A Olmos; A J Balm; R B Keus; H van Tinteren; R P Takes; S H Muller; A M Bruce; C A Hoefnagel; F J Hilgers
Journal:  Eur J Nucl Med       Date:  1996-11

10.  The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.

Authors:  K C M Leung; A S McMillan; M C M Wong; W K Leung; M Y Mok; C S Lau
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.